Monitoring of Donor-specific Antibodies After Treatment With Immunoglobulins, Plasmapheresis and Rituximab in Lung Transplantation

Clinical trial NCT03798860 · COMPLETED

Trial details

NCT number: NCT03798860
Sponsor: Hannover Medical School
Status: COMPLETED
Study type: OBSERVATIONAL

Lung Transplantation Donor-specific Anti-human Leukocyte Antigen(HLA) Antibodies

Start date: 2018-10-01
Primary completion: 2025-12-31
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.